4.7 Review

Deep learning in next-generation sequencing

Journal

DRUG DISCOVERY TODAY
Volume 26, Issue 1, Pages 173-180

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2020.10.002

Keywords

-

Funding

  1. Federal Ministry of Education and Research (BMBF)

Ask authors/readers for more resources

Next-generation sequencing (NGS) methods lie at the heart of large parts of biological and medical research. Their fundamental importance has created a continuously increasing demand for processing and analysis methods of the data sets produced, addressing questions such as variant calling, metagenomic classification and quantification, genomic feature detection, or downstream analysis in larger biological or medical contexts. In addition to classical algorithmic approaches, machine-learning (ML) techniques are often used for such tasks. In particular, deep learning (DL) methods that use multilayered artificial neural networks (ANNs) for supervised, semisupervised, and unsupervised learning have gained significant traction for such applications. Here, we highlight important network architectures, application areas, and DL frameworks in a NGS context.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available